Navidea strikes radiopharmaceutical agreement with PETNet

08/22/2013 | (free registration)

A radiopharmaceutical manufacturing agreement has been solidified between PETNet Solutions and Navidea Biopharmaceuticals in support of clinical trials evaluating NAV4694. According to Navidea, the F-18 labeled PET imaging agent is being tested in patients with symptoms of cognitive disorders including Alzheimer's disease.

View Full Article in: (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC